| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/23/2007 | CN1966027A Drink for relieving stomach ache |
| 05/23/2007 | CN1966022A Chinese medicinal formulation for treating children's diarrhea and method for preparing same |
| 05/23/2007 | CN1966020A Chinese medicinal pill with date for treating liver and kidney diseases |
| 05/23/2007 | CN1966019A Effervescence tablet having hawthorn, preparation process and testing method thereof |
| 05/23/2007 | CN1966016A Drink for treating infant diarrhea |
| 05/23/2007 | CN1966011A Medicament for clearing heat, resolving phlegm and caring liver used for infant |
| 05/23/2007 | CN1965997A Chinese medicinal wine |
| 05/23/2007 | CN1965995A Medicament for treating coronary heart disease and senile deficiency syndrome and preparation process thereof |
| 05/23/2007 | CN1965989A Powder having favorable effect in the treatment of stomach ache |
| 05/23/2007 | CN1965982A Chinese medicine for lowering blood fat and protecting liver and method for preparing same |
| 05/23/2007 | CN1965979A Medicament for treating hepatitis B |
| 05/23/2007 | CN1965977A Medicinal decoction for treating liver stagnation type fatty liver and method for preparing same |
| 05/23/2007 | CN1965975A Medicinal liquid having favorable effect on the treatment of liver cirrhosis |
| 05/23/2007 | CN1965968A Orally administered medicinal powder for treating gastric diseases |
| 05/23/2007 | CN1965965A Drink capable of treating fatty liver |
| 05/23/2007 | CN1965953A Compound medicinal granule capable of tonifying kidney and replenishing qi and method for preparing same |
| 05/23/2007 | CN1965952A Refined medicament capable of replenishing qi and primordial essence |
| 05/23/2007 | CN1965943A Drink for relieving foul breath |
| 05/23/2007 | CN1965937A Medicament for treating toothache |
| 05/23/2007 | CN1965934A Medicinal decoction for treating bleeding type ascites due to cirrhosis and method for preparing same |
| 05/23/2007 | CN1965930A Duodenum targeted orally administered pharmaceutical formulation, preparation method and application thereof |
| 05/23/2007 | CN1965910A Medicament for treating gastrointestinal diseases |
| 05/23/2007 | CN1965897A Chinese medicinal composition for resisting hepatic fibrosis and method for preparing same |
| 05/23/2007 | CN1965891A Remedy for treating poultry bacillary dysentery and livestock gastrointestinal inflammation |
| 05/23/2007 | CN1965883A Anti-hepatitis B compound formulation, preparation process and application thereof |
| 05/23/2007 | CN1965855A Microecological formulation for treating and caring mouth cavity disease |
| 05/23/2007 | CN1965845A Drop pills of ginsenoside monomer and preparation process thereof |
| 05/23/2007 | CN1965829A Injection of palonosetron and preparation process thereof |
| 05/23/2007 | CN1965826A Compound medicament for treating gastric diseases |
| 05/23/2007 | CN1965804A Hydrogel suppository of berberine hydrochloride and preparation process thereof |
| 05/23/2007 | CN1965650A Multiple metal ion chelated green antibacterial agent of chitosan |
| 05/23/2007 | CN1317389C Structure of antisense digonucleotide for inhibiting fibronectin expression and use |
| 05/23/2007 | CN1317301C Modulation of IL-2-and IL-15-mediated T cell responses |
| 05/23/2007 | CN1317023C Xiangsha yangwei hard capsule for nourishing stomach, and its prepn. method |
| 05/23/2007 | CN1317010C Dripping pill for tonifying heart and kidney and its preparing method |
| 05/23/2007 | CN1317008C Plant extract preparation for preventing and controlling constipation of middle and old age people, and its preparation method |
| 05/23/2007 | CN1316998C Powder for treating hepatitis B and liver cirrhosis |
| 05/23/2007 | CN1316996C Compound Qingdai agent for inflammatory intestinal diseases and preparation method |
| 05/23/2007 | CN1316984C Use of acalypha copperleaf water extract in preparing medicine for treating chronic ulcerative colitis |
| 05/23/2007 | CN1316959C Acanthopanax bark-ginseng-Chinese angelica root-astragalus root dripping pill and its preparing method |
| 05/23/2007 | CN1316906C Method for preparing micron pearl fermented soybean milk taken at night for assisting sleep, tonifying intestine and supplying calcium |
| 05/22/2007 | US7220880 For therapy of diabetes mellitus, cardiovascular disease, obesity, Syndrome X and gastrointestinal disease, such as, inflammatory bowel disease |
| 05/22/2007 | US7220867 Dissolving with crystal growth inihibitos; drying |
| 05/22/2007 | US7220856 Substituted quinoline CCR5 receptor antagonists |
| 05/22/2007 | US7220834 FHIT proteins and nucleic acids and methods based thereon |
| 05/22/2007 | US7220771 Jun n-terminal kinase inhibitors |
| 05/22/2007 | US7220769 Azolylbenzamides and analogues and their use for treating osteoporosis |
| 05/22/2007 | US7220765 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 05/22/2007 | US7220754 Mono-ester and asymmetrically substatuted di-ester pro-drugs of dopamide D1 receptor agonists |
| 05/22/2007 | US7220753 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors |
| 05/22/2007 | US7220752 Liver selective glucocorticoid receptor antagonists; lowering blood glucose levels; 3,5-dibromo-4-(5-isopropyl-2-(3-methylbenzoyl)-4-(3-methyl-3-b utenyloxy)phenoxy)-phenylacetic acid for example |
| 05/22/2007 | US7220750 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders |
| 05/22/2007 | US7220739 Therapeutic application of pro-apoptotic benzodiazepines |
| 05/22/2007 | US7220735 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion |
| 05/22/2007 | US7220722 Lipoprotein-regulating medicants |
| 05/22/2007 | US7220420 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 05/22/2007 | US7220418 Delivery of trefoil peptides |
| 05/22/2007 | CA2389032C Preventive or therapeutic agents for inflammatory diseases of intestine |
| 05/22/2007 | CA2323680C Orally disintegrable tablets |
| 05/22/2007 | CA2286870C Indazole amide compounds as serotoninergic agents |
| 05/18/2007 | WO2007056440A1 Treatment and prevention of adverse liver conditions using gallium |
| 05/18/2007 | WO2007055598A1 Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits |
| 05/18/2007 | WO2007055184A1 Therapeutic or prophylactic agent for functional bowel disorder |
| 05/18/2007 | WO2007054197A1 Food products, ingredients therefor and use of those food products and ingredients |
| 05/18/2007 | WO2007054030A1 Polyethylene glycol modifications of thymosin alpha-1 |
| 05/18/2007 | WO2007053946A1 Method of treating diabetes and/or obesity with reduced nausea side effects using an insulinotropic peptide conjugated to albumin |
| 05/18/2007 | WO2007053935A1 Pharmaceutical compositions comprising polymeric binders with non-hydrolysable covalent bonds and their use in treating celiac disease |
| 05/18/2007 | WO2007031845A3 Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation |
| 05/18/2007 | WO2007023073A3 Bicyclic heterocycles medicaments comprising said compounds use and method for production thereof |
| 05/18/2007 | WO2007013944A3 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 05/18/2007 | WO2006106438A3 Modulators of ppar activity |
| 05/18/2007 | WO2006024955A8 Azabicyclic amine histamine-3 receptor antagonists |
| 05/18/2007 | WO2006015775A3 Egfr kinase inhibitor combinations for treating respiratory and gastrointestinal disorders |
| 05/18/2007 | CA2637782A1 Treatment and prevention of adverse liver conditions using gallium |
| 05/18/2007 | CA2632697A1 Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits |
| 05/18/2007 | CA2629327A1 Pharmaceutical compositions comprising polymeric binders with non-hydrolysable covalent bonds and their use in treating celiac disease |
| 05/18/2007 | CA2628971A1 Therapeutic or prophylactic agent for functional bowel disorder |
| 05/17/2007 | US20070112046 2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors |
| 05/17/2007 | US20070112029 Piperidine compound and process for preparing the same |
| 05/17/2007 | US20070112026 Carbostyril derivatives for accelerating salivation |
| 05/17/2007 | US20070112021 Inhibiting gastric acid secretion |
| 05/17/2007 | US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma |
| 05/17/2007 | US20070111945 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 05/17/2007 | US20070111942 For detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 05/17/2007 | US20070111940 Peptide agonists of GLP-1 activity |
| 05/17/2007 | US20070111934 Procaspase 1 activation inhibitor |
| 05/17/2007 | US20070111266 Antibodies to murine zcytor17 ligand |
| 05/17/2007 | US20070110806 Core contains acid-unstable drug and disintegrant, and release-controlling coating contains water-insoluble polymer, an enteric polymer and hydrophobic wax; capsules |
| 05/17/2007 | US20070110723 Delivery of trefoil peptides |
| 05/17/2007 | US20070110714 Medicinal composition for treatment of chronic hepatitis c |
| 05/16/2007 | EP1785132A1 Constitutional function-improving agents |
| 05/16/2007 | EP1784404A1 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof |
| 05/16/2007 | EP1784403A1 Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof |
| 05/16/2007 | EP1784224A2 Egfr kinase inhibitor combinations for treating respiratory and gastrointestinal disorders |
| 05/16/2007 | EP1784218A1 Nutricional composition comprising immunoglobulins and oligosaccharides |
| 05/16/2007 | EP1784182A1 2-sulfanyl-benzimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 05/16/2007 | EP1615634B1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 05/16/2007 | EP1448544B1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/16/2007 | EP1372700B1 Stable aqueous solutions of granulocyte macrophage colony-stimulating factor |
| 05/16/2007 | EP1305285B1 N-substituted indoles useful in the treatment of diabetes |